XHKG0401
Market cap4mUSD
Dec 19, Last price
0.06HKD
1D
0.00%
Jan 2017
-98.46%
IPO
-98.36%
Name
Wanjia Group Holdings Ltd
Chart & Performance
Profile
Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 181,092 4.25% | 173,702 12.19% | 154,823 35.71% | |||||||
Cost of revenue | 191,899 | 176,148 | 152,439 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (10,807) | (2,446) | 2,384 | |||||||
NOPBT Margin | 1.54% | |||||||||
Operating Taxes | (854) | 517 | 2,246 | |||||||
Tax Rate | 94.21% | |||||||||
NOPAT | (9,953) | (2,963) | 138 | |||||||
Net income | (39,977) -2,296.54% | 1,820 -103.57% | (50,999) 1,024.32% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 4,055 | 10,019 | 2,732 | |||||||
Long-term debt | 25,454 | 32,863 | 39,240 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | 11,281 | 33,006 | 36,204 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 9,302 | 9,385 | 2,120 | |||||||
CAPEX | (3,409) | (3,914) | (6,979) | |||||||
Cash from investing activities | 674 | (3,844) | (6,933) | |||||||
Cash from financing activities | (1,042) | (802) | (14,969) | |||||||
FCF | (1,851) | 59,494 | (47,120) | |||||||
Balance | ||||||||||
Cash | 18,228 | 9,876 | 5,768 | |||||||
Long term investments | ||||||||||
Excess cash | 9,173 | 1,191 | ||||||||
Stockholders' equity | (7,429) | 59,928 | 88,618 | |||||||
Invested Capital | 98,224 | 142,882 | 147,576 | |||||||
ROIC | 0.09% | |||||||||
ROCE | 1.62% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 560,222 | 560,222 | 560,222 | |||||||
Price | 0.18 | |||||||||
Market cap | 100,840 | |||||||||
EV | 135,876 | |||||||||
EBITDA | (394) | 9,477 | 15,127 | |||||||
EV/EBITDA | 14.34 | |||||||||
Interest | 1,711 | 2,018 | 1,308 | |||||||
Interest/NOPBT | 54.87% |